Mao Sheng Duan

Corporate Officer/Principal presso HD Biosciences Co., Ltd.

Consumer Services

Health Services

Profilo

Mao Sheng Duan is currently the Vice President & Head-Medicinal Chemistry at HD Biosciences Co., Ltd.
Prior to this, he worked as the Chief Scientist at Glaxosmithkline China Ltd.
Dr. Duan received his doctorate degree from The Ohio State University and his undergraduate and graduate degrees from Central China Normal University and Nankai University respectively.

Posizioni attive di Mao Sheng Duan

Società	Posizione	Inizio
HD Biosciences Co., Ltd. HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China.	Corporate Officer/Principal	-

Tutte le posizioni attive di Mao Sheng Duan

Precedenti posizioni note di Mao Sheng Duan

Società	Posizione	Fine
Glaxosmithkline China Ltd.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mao Sheng Duan

Formazione di Mao Sheng Duan

The Ohio State University	Graduate Degree
Nankai University	Graduate Degree
Central China Normal University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mao Sheng Duan

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
HD Biosciences Co., Ltd. HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China.	Health Services
Glaxosmithkline China Ltd.